BPG is committed to discovery and dissemination of knowledge
-
|
Homepage
|
-
|
Online Submission
|
- Number of total visits
-
3538119
- Number of visits today
- 5658
- Number of downloads
-
2720943
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Rojas-Chavarro LF, de Mora F. Extrapolation: Experience gained from original biologics. Drug Discov Today 2021;26:2003-13. [PMID: 34022458 DOI: 10.1016/j.drudis.2021.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
de Mora F, Balsa A, Cornide-Santos M, Carrascosa JM, Marsal S, P Gisbert J, Abad MA, F Duarte R, Wiechmann M, Martínez R. Biosimilar and interchangeable: Inseparable scientific concepts? Br J Clin Pharmacol 2019;85:2460-3. [PMID: 31486117 DOI: 10.1111/bcp.14089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
3 |
Afzali A, Furtner D, Melsheimer R, Molloy PJ. The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable. Adv Ther 2021;38:2077-93. [PMID: 33745111 DOI: 10.1007/s12325-021-01688-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
4 |
Puig L, Carrascosa JM, Notario J. Biosimilars in the Treatment of Psoriasis: An Update. Actas Dermosifiliogr (Engl Ed) 2020;111:809-14. [PMID: 32860750 DOI: 10.1016/j.ad.2020.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
5 |
Macaluso FS, Cummings JF, Atreya R, Choi J, Orlando A. A Systematic Review on Infliximab Biosimilar SB2: From Pre-Clinical Data to Real-World Evidence. Expert Opin Biol Ther 2021. [PMID: 34314284 DOI: 10.1080/14712598.2021.1958778] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345